ABBV-744 in clinical trials for non-small cell lung cancer (NSCLC) Options
RUNX1 can be a grasp transcription component that regulates the expression of many genes essential for hematopoiesis. Studies implied the RUNX1
Celastrol was recognized for a Myb inhibitor that suppressed C/EBPβ action and repressed AML cell proliferation inside of a primary mouse design.61